The Bill & Melinda Gates Foundation awarded a $3.3 million grant to GreenLight Biosciences to develop gene therapies revolving around messenger RNA (mRNA) — the intermediate molecule between DNA and proteins — for sickle cell disease (SCD) and other global health challenges.
Lewis & Clark Ventures was founded by former operators with the conviction that innovation and entrepreneurial talent are plentiful outside of traditional capital centers. We partner with high potential Late Seed and Series A stage B2B software companies. Our vision for success is to become a trusted partner to every entrepreneur that we back and assist in their journey towards scale and significance.
